RNA technology gets public image lift; Lilly acquires another biotech; GOP gambles midterm fortunes on MAHA movement.

Built in collaboration with Google Cloud, Eversana’s platform combines agentic AI orchestration, workflow automation and ...

Some of the sharpest strategic thinking comes from outside of pharma. Here’s how marketers can foster those networks.

Growing numbers of Americans are looking abroad, particularly to Greece and Spain, to escape the high cost of fertility treatments in the U.S., where such procedures are often not covered by insurance ...

The agency said booth materials for Alar’s investigational ALA-3000 made unsupported safety and efficacy claims and failed to ...

Following Clausen’s exit, Lauren Bayse took over as Etsy’s global head of communications and corporate affairs, leading the company’s corporate, consumer and internal comms teams as well as its impact ...

In this episode, Greg Novello, managing director of Spherico, joins Jennifer Brunner, EVP and team lead at AnswerSuite, to ...

Novo and Lilly step up fight against counterfeit weight-loss drugs; Updated COVID shots enter the scene; Walmart settles for ...

One of the most important relationships pharma marketers manage is with their regulatory team — often a group of people with ...

A woman in Washington state discovered that unlike mammograms, breast MRIs aren’t universally covered as zero-cost preventive ...

Enforcement isn’t waiting on the rule. FDA sent almost no untitled letters in 2023 or 2024, then roughly 40 in one wave in September 2025, plus about 100 cease-and-desist letters. That pace has ...